Jiangsu Apon Medical Hits Day Low at CNY 29.23 Amid Price Pressure

Jiangsu Apon Medical Technology Co., Ltd. experienced significant volatility on March 20, 2026, with the stock hitting an intraday low of CNY 29.23, reflecting a decline of 9.81% for the day. This performance starkly contrasts with the broader market, as the China Shanghai Composite index fell by only 1.24% during the same period. Over the past week, Jiangsu Apon has seen a notable drop of 15.91%, while its monthly performance shows a decrease of 15.08%. Despite these short-term challenges, the company has demonstrated a year-to-date gain of 5.33%, and a substantial increase of 29.68% over the past year, outpacing the China Shanghai Composite's 16.08% growth. However, the company faces underlying financial pressures, with net sales growing at a modest annual rate of 0.93% and operating profit declining significantly by 184.95% over the last five years. The stock's high dividend yield of 0.40% and a market capitalization of CNY 2,030 million highlight its small-cap status within the pharmaceuticals and biotechnology sector.